Effect of Spacing Intravenous Bisphosphonates in Patients With Multiple Myeloma in Plateau Phase

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404715
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evolving Therapeutic Role of Bisphosphonates in Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2005English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

Blood Cancer Journal
OncologyHematology
2015English

Prevalence of Apical Periodontitis in Patients With Multiple Myeloma

Medicina Oral, Patologia Oral y Cirugia Bucal
MedicineOtorhinolaryngologySurgeryDentistry
2020English

The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future

Oncologist
Cancer ResearchMedicineOncology
2011English

Effect of Thalidomide on Stem Cell Collection and Engraftment in Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2003English

Management of Older Patients With Multiple Myeloma

Blood Reviews
OncologyHematology
2011English

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research
Medicine
2010English

Phase I/Ii Study of Carfilzomib, Bendamustine, and Dexamethasone (CBD) in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2020English

Carfilzomib Monotherapy in Japanese Patients With Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

Cancer Science
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy